Table of Content

1 Report Overview
1.1 Anti-Infective Vaccines Definition
1.2 Market by Type
1.2.1 Global Anti-Infective Vaccines Market Size Growth Rate by Type, 2018 VS 2022 VS 2034
1.2.2 Inactivated Vaccines
1.2.3 Conjugate Vaccines
1.2.4 Live/attenuated Vaccines
1.3 Market Segment by Application
1.3.1 Global Anti-Infective Vaccines Market Size Growth Rate by Application, 2018 VS 2022 VS 2034
1.3.2 Bacterial Diseases
1.3.3 Viral Diseases
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Anti-Infective Vaccines Sales
2.1 Global Anti-Infective Vaccines Revenue Estimates and Forecasts 2018-2034
2.2 Global Anti-Infective Vaccines Revenue by Region: 2018 VS 2022 VS 2034
2.3 Global Anti-Infective Vaccines Revenue by Region
2.3.1 Global Anti-Infective Vaccines Revenue by Region (2018-2024)
2.3.2 Global Anti-Infective Vaccines Revenue by Region (2024-2034)
2.4 Global Anti-Infective Vaccines Sales Quantity Estimates and Forecasts 2018-2034
2.5 Global Anti-Infective Vaccines Sales Quantity by Region: 2018 VS 2022 VS 2034
2.6 Global Anti-Infective Vaccines Sales Quantity by Region
2.6.1 Global Anti-Infective Vaccines Sales Quantity by Region (2018-2024)
2.6.2 Global Anti-Infective Vaccines Sales Quantity by Region (2024-2034)
2.7 North America
2.8 Europe
2.9 China
2.10 APAC (excluding China)
2.11 Middle East, Africa and Latin America
3 Competition by Manufacturers
3.1 Global Anti-Infective Vaccines Sales Quantity by Manufacturers
3.1.1 Global Anti-Infective Vaccines Sales Quantity by Manufacturers (2018-2024)
3.1.2 Global Anti-Infective Vaccines Sales Quantity Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Companies by Anti-Infective Vaccines Sales in 2022
3.2 Global Anti-Infective Vaccines Revenue by Manufacturers
3.2.1 Global Anti-Infective Vaccines Revenue by Manufacturers (2018-2024)
3.2.2 Global Anti-Infective Vaccines Revenue Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Anti-Infective Vaccines Revenue in 2022
3.3 Global Anti-Infective Vaccines Sales Price by Manufacturers
3.4 Global Key Players of Anti-Infective Vaccines, Industry Ranking, 2021 VS 2022
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Anti-Infective Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Anti-Infective Vaccines, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Anti-Infective Vaccines, Product Offered and Application
3.8 Global Key Manufacturers of Anti-Infective Vaccines, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Estimates and Forecasts by Type
4.1 Global Anti-Infective Vaccines Sales Quantity by Type
4.1.1 Global Anti-Infective Vaccines Historical Sales Quantity by Type (2018-2024)
4.1.2 Global Anti-Infective Vaccines Forecasted Sales Quantity by Type (2024-2034)
4.1.3 Global Anti-Infective Vaccines Sales Quantity Market Share by Type (2018-2034)
4.2 Global Anti-Infective Vaccines Revenue by Type
4.2.1 Global Anti-Infective Vaccines Historical Revenue by Type (2018-2024)
4.2.2 Global Anti-Infective Vaccines Forecasted Revenue by Type (2024-2034)
4.2.3 Global Anti-Infective Vaccines Revenue Market Share by Type (2018-2034)
4.3 Global Anti-Infective Vaccines Price by Type
4.3.1 Global Anti-Infective Vaccines Price by Type (2018-2024)
4.3.2 Global Anti-Infective Vaccines Price Forecast by Type (2024-2034)
5 Market Size by Application
5.1 Global Anti-Infective Vaccines Sales Quantity by Application
5.1.1 Global Anti-Infective Vaccines Historical Sales Quantity by Application (2018-2024)
5.1.2 Global Anti-Infective Vaccines Forecasted Sales Quantity by Application (2024-2034)
5.1.3 Global Anti-Infective Vaccines Sales Quantity Market Share by Application (2018-2034)
5.2 Global Anti-Infective Vaccines Revenue by Application
5.2.1 Global Anti-Infective Vaccines Historical Revenue by Application (2018-2024)
5.2.2 Global Anti-Infective Vaccines Forecasted Revenue by Application (2024-2034)
5.2.3 Global Anti-Infective Vaccines Revenue Market Share by Application (2018-2034)
5.3 Global Anti-Infective Vaccines Price by Application
5.3.1 Global Anti-Infective Vaccines Price by Application (2018-2024)
5.3.2 Global Anti-Infective Vaccines Price Forecast by Application (2024-2034)
6 North America
6.1 North America Anti-Infective Vaccines Sales by Company
6.1.1 North America Anti-Infective Vaccines Revenue by Company (2018-2024)
6.1.2 North America Anti-Infective Vaccines Sales Quantity by Company (2018-2024)
6.2 North America Anti-Infective Vaccines Market Size by Type
6.2.1 North America Anti-Infective Vaccines Sales Quantity by Type (2018-2034)
6.2.2 North America Anti-Infective Vaccines Revenue by Type (2018-2034)
6.3 North America Anti-Infective Vaccines Market Size by Application
6.3.1 North America Anti-Infective Vaccines Sales Quantity by Application (2018-2034)
6.3.2 North America Anti-Infective Vaccines Revenue by Application (2018-2034)
6.4 North America Anti-Infective Vaccines Market Size by Country
6.4.1 North America Anti-Infective Vaccines Revenue by Country: 2018 VS 2022 VS 2034
6.4.2 North America Anti-Infective Vaccines Revenue by Country (2018-2034)
6.4.3 North America Anti-Infective Vaccines Sales Quantity by Country (2018-2034)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Anti-Infective Vaccines Sales by Company
7.1.1 Europe Anti-Infective Vaccines Sales Quantity by Company (2018-2024)
7.1.2 Europe Anti-Infective Vaccines Revenue by Company (2018-2024)
7.2 Europe Anti-Infective Vaccines Market Size by Type
7.2.1 Europe Anti-Infective Vaccines Sales Quantity by Type (2018-2034)
7.2.2 Europe Anti-Infective Vaccines Revenue by Type (2018-2034)
7.3 Europe Anti-Infective Vaccines Market Size by Application
7.3.1 Europe Anti-Infective Vaccines Sales Quantity by Application (2018-2034)
7.3.2 Europe Anti-Infective Vaccines Revenue by Application (2018-2034)
7.4 Europe Anti-Infective Vaccines Market Size by Country
7.4.1 Europe Anti-Infective Vaccines Revenue by Country: 2018 VS 2022 VS 2034
7.4.2 Europe Anti-Infective Vaccines Revenue by Country (2018-2034)
7.4.3 Europe Anti-Infective Vaccines Sales Quantity by Country (2018-2034)
7.4.4 Germany
7.4.5 France
7.4.6 U.K.
7.4.7 Italy
7.4.8 Russia
8 China
8.1 China Anti-Infective Vaccines Sales by Company
8.1.1 China Anti-Infective Vaccines Sales Quantity by Company (2018-2024)
8.1.2 China Anti-Infective Vaccines Revenue by Company (2018-2024)
8.2 China Anti-Infective Vaccines Market Size by Type
8.2.1 China Anti-Infective Vaccines Sales Quantity by Type (2018-2034)
8.2.2 China Anti-Infective Vaccines Revenue by Type (2018-2034)
8.3 China Anti-Infective Vaccines Market Size by Application
8.3.1 China Anti-Infective Vaccines Sales Quantity by Application (2018-2034)
8.3.2 China Anti-Infective Vaccines Revenue by Application (2018-2034)
9 APAC (excluding China)
9.1 APAC Anti-Infective Vaccines Sales by Company
9.1.1 APAC Anti-Infective Vaccines Sales Quantity by Company (2018-2024)
9.1.2 APAC Anti-Infective Vaccines Revenue by Company (2018-2024)
9.2 APAC Anti-Infective Vaccines Market Size by Type
9.2.1 APAC Anti-Infective Vaccines Sales Quantity by Type (2018-2034)
9.2.2 APAC Anti-Infective Vaccines Revenue by Type (2018-2034)
9.3 APAC Anti-Infective Vaccines Market Size by Application
9.3.1 APAC Anti-Infective Vaccines Sales Quantity by Application (2018-2034)
9.3.2 APAC Anti-Infective Vaccines Revenue by Application (2018-2034)
9.4 APAC Anti-Infective Vaccines Market Size by Region
9.4.1 APAC Anti-Infective Vaccines Revenue by Region: 2018 VS 2022 VS 2034
9.4.2 APAC Anti-Infective Vaccines Revenue by Region (2018-2034)
9.4.3 APAC Anti-Infective Vaccines Sales Quantity by Region (2018-2034)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Anti-Infective Vaccines Sales by Company
10.1.1 Middle East, Africa and Latin America Anti-Infective Vaccines Sales Quantity by Company (2018-2024)
10.1.2 Middle East, Africa and Latin America Anti-Infective Vaccines Revenue by Company (2018-2024)
10.2 Middle East, Africa and Latin America Anti-Infective Vaccines Market Size by Type
10.2.1 Middle East, Africa and Latin America Anti-Infective Vaccines Sales Quantity by Type (2018-2034)
10.2.2 Middle East, Africa and Latin America Anti-Infective Vaccines Revenue by Type (2018-2034)
10.3 Middle East, Africa and Latin America Anti-Infective Vaccines Market Size by Application
10.3.1 Middle East, Africa and Latin America Anti-Infective Vaccines Sales Quantity by Application (2018-2034)
10.3.2 Middle East, Africa and Latin America Anti-Infective Vaccines Revenue by Application (2018-2034)
10.4 Middle East, Africa and Latin America Anti-Infective Vaccines Market Size by Country
10.4.1 Middle East, Africa and Latin America Anti-Infective Vaccines Revenue by Country: 2018 VS 2022 VS 2034
10.4.2 Middle East, Africa and Latin America Anti-Infective Vaccines Revenue by Country (2018-2034)
10.4.3 Middle East, Africa and Latin America Anti-Infective Vaccines Sales Quantity by Country (2018-2034)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Israel
10.4.8 GCC Countries
11 Company Profiles
11.1 Emergent BioDefense Operations Lansing Inc.
11.1.1 Emergent BioDefense Operations Lansing Inc. Company Information
11.1.2 Emergent BioDefense Operations Lansing Inc. Overview
11.1.3 Emergent BioDefense Operations Lansing Inc. Anti-Infective Vaccines Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.1.4 Emergent BioDefense Operations Lansing Inc. Anti-Infective Vaccines Products and Services
11.1.5 Emergent BioDefense Operations Lansing Inc. Anti-Infective Vaccines SWOT Analysis
11.1.6 Emergent BioDefense Operations Lansing Inc. Recent Developments
11.2 Sanofi Pasteur
11.2.1 Sanofi Pasteur Company Information
11.2.2 Sanofi Pasteur Overview
11.2.3 Sanofi Pasteur Anti-Infective Vaccines Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.2.4 Sanofi Pasteur Anti-Infective Vaccines Products and Services
11.2.5 Sanofi Pasteur Anti-Infective Vaccines SWOT Analysis
11.2.6 Sanofi Pasteur Recent Developments
11.3 Merck & Co.
11.3.1 Merck & Co. Company Information
11.3.2 Merck & Co. Overview
11.3.3 Merck & Co. Anti-Infective Vaccines Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.3.4 Merck & Co. Anti-Infective Vaccines Products and Services
11.3.5 Merck & Co. Anti-Infective Vaccines SWOT Analysis
11.3.6 Merck & Co. Recent Developments
11.4 MedImmune LLC
11.4.1 MedImmune LLC Company Information
11.4.2 MedImmune LLC Overview
11.4.3 MedImmune LLC Anti-Infective Vaccines Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.4.4 MedImmune LLC Anti-Infective Vaccines Products and Services
11.4.5 MedImmune LLC Anti-Infective Vaccines SWOT Analysis
11.4.6 MedImmune LLC Recent Developments
11.5 Novartis Vaccines
11.5.1 Novartis Vaccines Company Information
11.5.2 Novartis Vaccines Overview
11.5.3 Novartis Vaccines Anti-Infective Vaccines Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.5.4 Novartis Vaccines Anti-Infective Vaccines Products and Services
11.5.5 Novartis Vaccines Anti-Infective Vaccines SWOT Analysis
11.5.6 Novartis Vaccines Recent Developments
11.6 Diagnostics Ltd.
11.6.1 Diagnostics Ltd. Company Information
11.6.2 Diagnostics Ltd. Overview
11.6.3 Diagnostics Ltd. Anti-Infective Vaccines Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.6.4 Diagnostics Ltd. Anti-Infective Vaccines Products and Services
11.6.5 Diagnostics Ltd. Anti-Infective Vaccines SWOT Analysis
11.6.6 Diagnostics Ltd. Recent Developments
11.7 Intercell Biomedical
11.7.1 Intercell Biomedical Company Information
11.7.2 Intercell Biomedical Overview
11.7.3 Intercell Biomedical Anti-Infective Vaccines Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.7.4 Intercell Biomedical Anti-Infective Vaccines Products and Services
11.7.5 Intercell Biomedical Anti-Infective Vaccines SWOT Analysis
11.7.6 Intercell Biomedical Recent Developments
11.8 MassBiologics
11.8.1 MassBiologics Company Information
11.8.2 MassBiologics Overview
11.8.3 MassBiologics Anti-Infective Vaccines Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.8.4 MassBiologics Anti-Infective Vaccines Products and Services
11.8.5 MassBiologics Anti-Infective Vaccines SWOT Analysis
11.8.6 MassBiologics Recent Developments
11.9 Barr Labs, Inc.
11.9.1 Barr Labs, Inc. Company Information
11.9.2 Barr Labs, Inc. Overview
11.9.3 Barr Labs, Inc. Anti-Infective Vaccines Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.9.4 Barr Labs, Inc. Anti-Infective Vaccines Products and Services
11.9.5 Barr Labs, Inc. Anti-Infective Vaccines SWOT Analysis
11.9.6 Barr Labs, Inc. Recent Developments
11.10 Organon Teknika Co.
11.10.1 Organon Teknika Co. Company Information
11.10.2 Organon Teknika Co. Overview
11.10.3 Organon Teknika Co. Anti-Infective Vaccines Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.10.4 Organon Teknika Co. Anti-Infective Vaccines Products and Services
11.10.5 Organon Teknika Co. Anti-Infective Vaccines SWOT Analysis
11.10.6 Organon Teknika Co. Recent Developments
11.11 GlaxoSmithKline Biologicals
11.11.1 GlaxoSmithKline Biologicals Company Information
11.11.2 GlaxoSmithKline Biologicals Overview
11.11.3 GlaxoSmithKline Biologicals Anti-Infective Vaccines Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.11.4 GlaxoSmithKline Biologicals Anti-Infective Vaccines Products and Services
11.11.5 GlaxoSmithKline Biologicals Recent Developments
11.12 CSL Ltd.
11.12.1 CSL Ltd. Company Information
11.12.2 CSL Ltd. Overview
11.12.3 CSL Ltd. Anti-Infective Vaccines Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.12.4 CSL Ltd. Anti-Infective Vaccines Products and Services
11.12.5 CSL Ltd. Recent Developments
11.13 ID Biomedical Co.
11.13.1 ID Biomedical Co. Company Information
11.13.2 ID Biomedical Co. Overview
11.13.3 ID Biomedical Co. Anti-Infective Vaccines Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.13.4 ID Biomedical Co. Anti-Infective Vaccines Products and Services
11.13.5 ID Biomedical Co. Recent Developments
11.14 Protein Sciences Co.
11.14.1 Protein Sciences Co. Company Information
11.14.2 Protein Sciences Co. Overview
11.14.3 Protein Sciences Co. Anti-Infective Vaccines Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.14.4 Protein Sciences Co. Anti-Infective Vaccines Products and Services
11.14.5 Protein Sciences Co. Recent Developments
11.15 Wyeth Pharmaceuticals, Inc.
11.15.1 Wyeth Pharmaceuticals, Inc. Company Information
11.15.2 Wyeth Pharmaceuticals, Inc. Overview
11.15.3 Wyeth Pharmaceuticals, Inc. Anti-Infective Vaccines Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.15.4 Wyeth Pharmaceuticals, Inc. Anti-Infective Vaccines Products and Services
11.15.5 Wyeth Pharmaceuticals, Inc. Recent Developments
11.16 Berna Biotech
11.16.1 Berna Biotech Company Information
11.16.2 Berna Biotech Overview
11.16.3 Berna Biotech Anti-Infective Vaccines Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.16.4 Berna Biotech Anti-Infective Vaccines Products and Services
11.16.5 Berna Biotech Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Anti-Infective Vaccines Value Chain Analysis
12.2 Anti-Infective Vaccines Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Anti-Infective Vaccines Production Mode & Process
12.4 Anti-Infective Vaccines Sales and Marketing
12.4.1 Anti-Infective Vaccines Sales Channels
12.4.2 Anti-Infective Vaccines Distributors
12.5 Anti-Infective Vaccines Customers
13 Market Dynamics
13.1 Anti-Infective Vaccines Industry Trends
13.2 Anti-Infective Vaccines Market Drivers
13.3 Anti-Infective Vaccines Market Challenges
13.4 Anti-Infective Vaccines Market Restraints
14 Key Findings
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Anti-Infective Vaccines Market Size Growth Rate (CAGR) by Type, 2018 VS 2022 VS 2034 (US$ Million)
Table 2. Major Manufacturers of Inactivated Vaccines
Table 3. Major Manufacturers of Conjugate Vaccines
Table 4. Major Manufacturers of Live/attenuated Vaccines
Table 5. Global Anti-Infective Vaccines Market Size Growth Rate (CAGR) by Application, 2018 VS 2022 VS 2034 (US$ Million)
Table 6. Global Anti-Infective Vaccines Revenue by Region: 2018 VS 2022 VS 2034 (US$ Million)
Table 7. Global Anti-Infective Vaccines Revenue by Region (2018-2024) & (US$ Million)
Table 8. Global Anti-Infective Vaccines Revenue Market Share by Region (2018-2024)
Table 9. Global Anti-Infective Vaccines Revenue by Region (2024-2034) & (US$ Million)
Table 10. Global Anti-Infective Vaccines Revenue Market Share by Region (2024-2034)
Table 11. Global Anti-Infective Vaccines Sales Quantity by Region: 2018 VS 2022 VS 2034 (K Units)
Table 12. Global Anti-Infective Vaccines Sales by Region (2018-2024) & (K Units)
Table 13. Global Anti-Infective Vaccines Sales Market Share by Region (2018-2024)
Table 14. Global Anti-Infective Vaccines Sales by Region (2024-2034) & (K Units)
Table 15. Global Anti-Infective Vaccines Sales Market Share by Region (2024-2034)
Table 16. Global Anti-Infective Vaccines Sales Quantity by Manufacturers (2018-2024) & (K Units)
Table 17. Global Anti-Infective Vaccines Sales Quantity Share by Manufacturers (2018-2024)
Table 18. Global Anti-Infective Vaccines Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 19. Global Anti-Infective Vaccines Revenue Share by Manufacturers (2018-2024)
Table 20. Global Anti-Infective Vaccines Price by Manufacturers 2018-2024 (US$/Unit)
Table 21. Global Key Players of Anti-Infective Vaccines, Industry Ranking, 2021 VS 2022
Table 22. Global Anti-Infective Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 23. Global Anti-Infective Vaccines by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anti-Infective Vaccines as of 2022)
Table 24. Global Key Manufacturers of Anti-Infective Vaccines, Manufacturing Base Distribution and Headquarters
Table 25. Global Key Manufacturers of Anti-Infective Vaccines, Product Offered and Application
Table 26. Global Key Manufacturers of Anti-Infective Vaccines, Date of Enter into This Industry
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Anti-Infective Vaccines Sales Quantity by Type (2018-2024) & (K Units)
Table 29. Global Anti-Infective Vaccines Sales Quantity by Type (2024-2034) & (K Units)
Table 30. Global Anti-Infective Vaccines Sales Quantity Share by Type (2018-2024)
Table 31. Global Anti-Infective Vaccines Sales Quantity Share by Type (2024-2034)
Table 32. Global Anti-Infective Vaccines Revenue by Type (2018-2024) & (US$ Million)
Table 33. Global Anti-Infective Vaccines Revenue by Type (2024-2034) & (US$ Million)
Table 34. Global Anti-Infective Vaccines Revenue Share by Type (2018-2024)
Table 35. Global Anti-Infective Vaccines Revenue Share by Type (2024-2034)
Table 36. Anti-Infective Vaccines Price by Type (2018-2024) & (US$/Unit)
Table 37. Global Anti-Infective Vaccines Price Forecast by Type (2024-2034) & (US$/Unit)
Table 38. Global Anti-Infective Vaccines Sales Quantity by Application (2018-2024) & (K Units)
Table 39. Global Anti-Infective Vaccines Sales Quantity by Application (2024-2034) & (K Units)
Table 40. Global Anti-Infective Vaccines Sales Quantity Share by Application (2018-2024)
Table 41. Global Anti-Infective Vaccines Sales Quantity Share by Application (2024-2034)
Table 42. Global Anti-Infective Vaccines Revenue by Application (2018-2024) & (US$ Million)
Table 43. Global Anti-Infective Vaccines Revenue by Application (2024-2034) & (US$ Million)
Table 44. Global Anti-Infective Vaccines Revenue Share by Application (2018-2024)
Table 45. Global Anti-Infective Vaccines Revenue Share by Application (2024-2034)
Table 46. Anti-Infective Vaccines Price by Application (2018-2024) & (US$/Unit)
Table 47. Global Anti-Infective Vaccines Price Forecast by Application (2024-2034) & (US$/Unit)
Table 48. North America Anti-Infective Vaccines Revenue by Company (2018-2024) & (US$ Million)
Table 49. North America Anti-Infective Vaccines Sales Quantity by Company (2018-2024) & (K Units)
Table 50. North America Anti-Infective Vaccines Sales Quantity by Type (2018-2024) & (K Units)
Table 51. North America Anti-Infective Vaccines Sales Quantity by Type (2024-2034) & (K Units)
Table 52. North America Anti-Infective Vaccines Revenue by Type (2018-2024) & (US$ Million)
Table 53. North America Anti-Infective Vaccines Revenue by Type (2024-2034) & (US$ Million)
Table 54. North America Anti-Infective Vaccines Sales Quantity by Application (2018-2024) & (K Units)
Table 55. North America Anti-Infective Vaccines Sales Quantity by Application (2024-2034) & (K Units)
Table 56. North America Anti-Infective Vaccines Revenue by Application (2018-2024) & (US$ Million)
Table 57. North America Anti-Infective Vaccines Revenue by Application (2024-2034) & (US$ Million)
Table 58. North America Anti-Infective Vaccines Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 59. North America Anti-Infective Vaccines Revenue by Country (2018-2024) & (US$ Million)
Table 60. North America Anti-Infective Vaccines Revenue by Country (2024-2034) & (US$ Million)
Table 61. North America Anti-Infective Vaccines Sales Quantity by Country (2018-2024) & (K Units)
Table 62. North America Anti-Infective Vaccines Sales Quantity by Country (2024-2034) & (K Units)
Table 63. Europe Anti-Infective Vaccines Sales Quantity by Company (2018-2024) & (K Units)
Table 64. Europe Anti-Infective Vaccines Revenue by Company (2018-2024) & (US$ Million)
Table 65. Europe Anti-Infective Vaccines Sales Quantity by Type (2018-2024) & (K Units)
Table 66. Europe Anti-Infective Vaccines Sales Quantity by Type (2024-2034) & (K Units)
Table 67. Europe Anti-Infective Vaccines Revenue by Type (2018-2024) & (US$ Million)
Table 68. Europe Anti-Infective Vaccines Revenue by Type (2024-2034) & (US$ Million)
Table 69. Europe Anti-Infective Vaccines Sales Quantity by Application (2018-2024) & (K Units)
Table 70. Europe Anti-Infective Vaccines Sales Quantity by Application (2024-2034) & (K Units)
Table 71. Europe Anti-Infective Vaccines Revenue by Application (2018-2024) & (US$ Million)
Table 72. Europe Anti-Infective Vaccines Revenue by Application (2024-2034) & (US$ Million)
Table 73. Europe Anti-Infective Vaccines Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 74. Europe Anti-Infective Vaccines Revenue by Country (2018-2024) & (US$ Million)
Table 75. Europe Anti-Infective Vaccines Revenue by Country (2024-2034) & (US$ Million)
Table 76. Europe Anti-Infective Vaccines Sales Quantity by Country (2018-2024) & (K Units)
Table 77. Europe Anti-Infective Vaccines Sales Quantity by Country (2024-2034) & (K Units)
Table 78. China Anti-Infective Vaccines Sales Quantity by Company (2018-2024) & (K Units)
Table 79. China Anti-Infective Vaccines Revenue by Company (2018-2024) & (US$ Million)
Table 80. China Anti-Infective Vaccines Sales Quantity by Type (2018-2024) & (K Units)
Table 81. China Anti-Infective Vaccines Sales Quantity by Type (2024-2034) & (K Units)
Table 82. China Anti-Infective Vaccines Revenue by Type (2018-2024) & (US$ Million)
Table 83. China Anti-Infective Vaccines Revenue by Type (2024-2034) & (US$ Million)
Table 84. China Anti-Infective Vaccines Sales Quantity by Application (2018-2024) & (K Units)
Table 85. China Anti-Infective Vaccines Sales Quantity by Application (2024-2034) & (K Units)
Table 86. China Anti-Infective Vaccines Revenue by Application (2018-2024) & (US$ Million)
Table 87. China Anti-Infective Vaccines Revenue by Application (2024-2034) & (US$ Million)
Table 88. APAC Anti-Infective Vaccines Sales Quantity by Company (2018-2024) & (K Units)
Table 89. APAC Anti-Infective Vaccines Revenue by Company (2018-2024) & (US$ Million)
Table 90. APAC Anti-Infective Vaccines Sales Quantity by Type (2018-2024) & (K Units)
Table 91. APAC Anti-Infective Vaccines Sales Quantity by Type (2024-2034) & (K Units)
Table 92. APAC Anti-Infective Vaccines Revenue by Type (2018-2024) & (US$ Million)
Table 93. APAC Anti-Infective Vaccines Revenue by Type (2024-2034) & (US$ Million)
Table 94. APAC Anti-Infective Vaccines Sales Quantity by Application (2018-2024) & (K Units)
Table 95. APAC Anti-Infective Vaccines Sales Quantity by Application (2024-2034) & (K Units)
Table 96. APAC Anti-Infective Vaccines Revenue by Application (2018-2024) & (US$ Million)
Table 97. APAC Anti-Infective Vaccines Revenue by Application (2024-2034) & (US$ Million)
Table 98. APAC Anti-Infective Vaccines Revenue by Region: 2018 VS 2022 VS 2034 (US$ Million)
Table 99. APAC Anti-Infective Vaccines Revenue by Region (2018-2024) & (US$ Million)
Table 100. APAC Anti-Infective Vaccines Revenue by Region (2024-2034) & (US$ Million)
Table 101. APAC Anti-Infective Vaccines Sales Quantity by Region (2018-2024) & (K Units)
Table 102. APAC Anti-Infective Vaccines Sales Quantity by Region (2024-2034) & (K Units)
Table 103. Middle East, Africa and Latin America Anti-Infective Vaccines Sales Quantity by Company (2018-2024) & (K Units)
Table 104. Middle East, Africa and Latin America Anti-Infective Vaccines Revenue by Company (2018-2024) & (US$ Million)
Table 105. Middle East, Africa and Latin America Anti-Infective Vaccines Sales Quantity by Type (2018-2024) & (K Units)
Table 106. Middle East, Africa and Latin America Anti-Infective Vaccines Sales Quantity by Type (2024-2034) & (K Units)
Table 107. Middle East, Africa and Latin America Anti-Infective Vaccines Revenue by Type (2018-2024) & (US$ Million)
Table 108. Middle East, Africa and Latin America Anti-Infective Vaccines Revenue by Type (2024-2034) & (US$ Million)
Table 109. Middle East, Africa and Latin America Anti-Infective Vaccines Sales Quantity by Application (2018-2024) & (K Units)
Table 110. Middle East, Africa and Latin America Anti-Infective Vaccines Sales Quantity by Application (2024-2034) & (K Units)
Table 111. Middle East, Africa and Latin America Anti-Infective Vaccines Revenue by Application (2018-2024) & (US$ Million)
Table 112. Middle East, Africa and Latin America Anti-Infective Vaccines Revenue by Application (2024-2034) & (US$ Million)
Table 113. Middle East, Africa and Latin America Anti-Infective Vaccines Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 114. Middle East, Africa and Latin America Anti-Infective Vaccines Revenue by Country (2018-2024) & (US$ Million)
Table 115. Middle East, Africa and Latin America Anti-Infective Vaccines Revenue by Country (2024-2034) & (US$ Million)
Table 116. Middle East, Africa and Latin America Anti-Infective Vaccines Sales Quantity by Country (2018-2024) & (K Units)
Table 117. Middle East, Africa and Latin America Anti-Infective Vaccines Sales Quantity by Country (2024-2034) & (K Units)
Table 118. Emergent BioDefense Operations Lansing Inc. Company Information
Table 119. Emergent BioDefense Operations Lansing Inc. Description and Overview
Table 120. Emergent BioDefense Operations Lansing Inc. Anti-Infective Vaccines Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2018-2024)
Table 121. Emergent BioDefense Operations Lansing Inc. Anti-Infective Vaccines Product and Services
Table 122. Emergent BioDefense Operations Lansing Inc. Anti-Infective Vaccines SWOT Analysis
Table 123. Emergent BioDefense Operations Lansing Inc. Recent Developments
Table 124. Sanofi Pasteur Company Information
Table 125. Sanofi Pasteur Description and Overview
Table 126. Sanofi Pasteur Anti-Infective Vaccines Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2018-2024)
Table 127. Sanofi Pasteur Anti-Infective Vaccines Product and Services
Table 128. Sanofi Pasteur Anti-Infective Vaccines SWOT Analysis
Table 129. Sanofi Pasteur Recent Developments
Table 130. Merck & Co. Company Information
Table 131. Merck & Co. Description and Overview
Table 132. Merck & Co. Anti-Infective Vaccines Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2018-2024)
Table 133. Merck & Co. Anti-Infective Vaccines Product and Services
Table 134. Merck & Co. Anti-Infective Vaccines SWOT Analysis
Table 135. Merck & Co. Recent Developments
Table 136. MedImmune LLC Company Information
Table 137. MedImmune LLC Description and Overview
Table 138. MedImmune LLC Anti-Infective Vaccines Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2018-2024)
Table 139. MedImmune LLC Anti-Infective Vaccines Product and Services
Table 140. MedImmune LLC Anti-Infective Vaccines SWOT Analysis
Table 141. MedImmune LLC Recent Developments
Table 142. Novartis Vaccines Company Information
Table 143. Novartis Vaccines Description and Overview
Table 144. Novartis Vaccines Anti-Infective Vaccines Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2018-2024)
Table 145. Novartis Vaccines Anti-Infective Vaccines Product and Services
Table 146. Novartis Vaccines Anti-Infective Vaccines SWOT Analysis
Table 147. Novartis Vaccines Recent Developments
Table 148. Diagnostics Ltd. Company Information
Table 149. Diagnostics Ltd. Description and Overview
Table 150. Diagnostics Ltd. Anti-Infective Vaccines Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2018-2024)
Table 151. Diagnostics Ltd. Anti-Infective Vaccines Product and Services
Table 152. Diagnostics Ltd. Anti-Infective Vaccines SWOT Analysis
Table 153. Diagnostics Ltd. Recent Developments
Table 154. Intercell Biomedical Company Information
Table 155. Intercell Biomedical Description and Overview
Table 156. Intercell Biomedical Anti-Infective Vaccines Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2018-2024)
Table 157. Intercell Biomedical Anti-Infective Vaccines Product and Services
Table 158. Intercell Biomedical Anti-Infective Vaccines SWOT Analysis
Table 159. Intercell Biomedical Recent Developments
Table 160. MassBiologics Company Information
Table 161. MassBiologics Description and Overview
Table 162. MassBiologics Anti-Infective Vaccines Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2018-2024)
Table 163. MassBiologics Anti-Infective Vaccines Product and Services
Table 164. MassBiologics Anti-Infective Vaccines SWOT Analysis
Table 165. MassBiologics Recent Developments
Table 166. Barr Labs, Inc. Company Information
Table 167. Barr Labs, Inc. Description and Overview
Table 168. Barr Labs, Inc. Anti-Infective Vaccines Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2018-2024)
Table 169. Barr Labs, Inc. Anti-Infective Vaccines Product and Services
Table 170. Barr Labs, Inc. Anti-Infective Vaccines SWOT Analysis
Table 171. Barr Labs, Inc. Recent Developments
Table 172. Organon Teknika Co. Company Information
Table 173. Organon Teknika Co. Description and Overview
Table 174. Organon Teknika Co. Anti-Infective Vaccines Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2018-2024)
Table 175. Organon Teknika Co. Anti-Infective Vaccines Product and Services
Table 176. Organon Teknika Co. Anti-Infective Vaccines SWOT Analysis
Table 177. Organon Teknika Co. Recent Developments
Table 178. GlaxoSmithKline Biologicals Company Information
Table 179. GlaxoSmithKline Biologicals Description and Overview
Table 180. GlaxoSmithKline Biologicals Anti-Infective Vaccines Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2018-2024)
Table 181. GlaxoSmithKline Biologicals Anti-Infective Vaccines Product and Services
Table 182. GlaxoSmithKline Biologicals Recent Developments
Table 183. CSL Ltd. Company Information
Table 184. CSL Ltd. Description and Overview
Table 185. CSL Ltd. Anti-Infective Vaccines Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2018-2024)
Table 186. CSL Ltd. Anti-Infective Vaccines Product and Services
Table 187. CSL Ltd. Recent Developments
Table 188. ID Biomedical Co. Company Information
Table 189. ID Biomedical Co. Description and Overview
Table 190. ID Biomedical Co. Anti-Infective Vaccines Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2018-2024)
Table 191. ID Biomedical Co. Anti-Infective Vaccines Product and Services
Table 192. ID Biomedical Co. Recent Developments
Table 193. Protein Sciences Co. Company Information
Table 194. Protein Sciences Co. Description and Overview
Table 195. Protein Sciences Co. Anti-Infective Vaccines Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2018-2024)
Table 196. Protein Sciences Co. Anti-Infective Vaccines Product and Services
Table 197. Protein Sciences Co. Recent Developments
Table 198. Wyeth Pharmaceuticals, Inc. Company Information
Table 199. Wyeth Pharmaceuticals, Inc. Description and Overview
Table 200. Wyeth Pharmaceuticals, Inc. Anti-Infective Vaccines Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2018-2024)
Table 201. Wyeth Pharmaceuticals, Inc. Anti-Infective Vaccines Product and Services
Table 202. Wyeth Pharmaceuticals, Inc. Recent Developments
Table 203. Berna Biotech Company Information
Table 204. Berna Biotech Description and Overview
Table 205. Berna Biotech Anti-Infective Vaccines Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2018-2024)
Table 206. Berna Biotech Anti-Infective Vaccines Product and Services
Table 207. Berna Biotech Recent Developments
Table 208. Key Raw Materials Lists
Table 209. Raw Materials Key Suppliers Lists
Table 210. Anti-Infective Vaccines Distributors List
Table 211. Anti-Infective Vaccines Customers List
Table 212. Anti-Infective Vaccines Market Trends
Table 213. Anti-Infective Vaccines Market Drivers
Table 214. Anti-Infective Vaccines Market Challenges
Table 215. Anti-Infective Vaccines Market Restraints
Table 216. Research Programs/Design for This Report
Table 217. Key Data Information from Secondary Sources
Table 218. Key Data Information from Primary Sources
List of Figures
Figure 1. Anti-Infective Vaccines Product Picture
Figure 2. Global Anti-Infective Vaccines Market Size Growth Rate by Type, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Anti-Infective Vaccines Market Share by Type in 2022 & 2034
Figure 4. Inactivated Vaccines Product Picture
Figure 5. Conjugate Vaccines Product Picture
Figure 6. Live/attenuated Vaccines Product Picture
Figure 7. Global Anti-Infective Vaccines Market Size Growth Rate by Application, 2018 VS 2022 VS 2034 (US$ Million)
Figure 8. Global Anti-Infective Vaccines Market Share by Application in 2022 & 2034
Figure 9. Bacterial Diseases
Figure 10. Viral Diseases
Figure 11. Anti-Infective Vaccines Report Years Considered
Figure 12. Global Anti-Infective Vaccines Revenue, (US$ Million), 2018 VS 2022 VS 2034
Figure 13. Global Anti-Infective Vaccines Revenue 2018-2034 (US$ Million)
Figure 14. Global Anti-Infective Vaccines Revenue Market Share by Region in Percentage: 2022 Versus 2034
Figure 15. Global Anti-Infective Vaccines Sales Quantity 2018-2034 (K Units)
Figure 16. Global Anti-Infective Vaccines Sales Quantity Market Share by Region (2018-2024)
Figure 17. Global Anti-Infective Vaccines Sales Quantity Market Share by Region (2024-2034)
Figure 18. North America Anti-Infective Vaccines Sales Quantity YoY (2018-2034) & (K Units)
Figure 19. North America Anti-Infective Vaccines Revenue YoY (2018-2034) & (US$ Million)
Figure 20. Europe Anti-Infective Vaccines Sales Quantity YoY (2018-2034) & (K Units)
Figure 21. Europe Anti-Infective Vaccines Revenue YoY (2018-2034) & (US$ Million)
Figure 22. China Anti-Infective Vaccines Sales Quantity YoY (2018-2034) & (K Units)
Figure 23. China Anti-Infective Vaccines Revenue YoY (2018-2034) & (US$ Million)
Figure 24. APAC Anti-Infective Vaccines Sales Quantity YoY (2018-2034) & (K Units)
Figure 25. APAC Anti-Infective Vaccines Revenue YoY (2018-2034) & (US$ Million)
Figure 26. Middle East, Africa and Latin America Anti-Infective Vaccines Sales Quantity YoY (2018-2034) & (K Units)
Figure 27. Middle East, Africa and Latin America Anti-Infective Vaccines Revenue YoY (2018-2034) & (US$ Million)
Figure 28. The Top 10 and Top 5 Players Market Share by Anti-Infective Vaccines Sales Quantity in 2022
Figure 29. The Top 10 and Top 5 Players Market Share by Anti-Infective Vaccines Revenue in 2022
Figure 30. Anti-Infective Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 31. Global Anti-Infective Vaccines Sales Quantity Market Share by Type (2018-2034)
Figure 32. Global Anti-Infective Vaccines Revenue Market Share by Type (2018-2034)
Figure 33. Global Anti-Infective Vaccines Sales Quantity Market Share by Application (2018-2034)
Figure 34. Global Anti-Infective Vaccines Revenue Market Share by Application (2018-2034)
Figure 35. North America Anti-Infective Vaccines Revenue Market Share by Company in 2022
Figure 36. North America Anti-Infective Vaccines Sales Quantity Market Share by Company in 2022
Figure 37. North America Anti-Infective Vaccines Sales Quantity Market Share by Type (2018-2034)
Figure 38. North America Anti-Infective Vaccines Revenue Market Share by Type (2018-2034)
Figure 39. North America Anti-Infective Vaccines Sales Quantity Market Share by Application (2018-2034)
Figure 40. North America Anti-Infective Vaccines Revenue Market Share by Application (2018-2034)
Figure 41. North America Anti-Infective Vaccines Revenue Share by Country (2018-2034)
Figure 42. North America Anti-Infective Vaccines Sales Quantity Share by Country (2018-2034)
Figure 43. U.S. Anti-Infective Vaccines Revenue (2018-2034) & (US$ Million)
Figure 44. Canada Anti-Infective Vaccines Revenue (2018-2034) & (US$ Million)
Figure 45. Europe Anti-Infective Vaccines Sales Quantity Market Share by Company in 2022
Figure 46. Europe Anti-Infective Vaccines Revenue Market Share by Company in 2022
Figure 47. Europe Anti-Infective Vaccines Sales Quantity Market Share by Type (2018-2034)
Figure 48. Europe Anti-Infective Vaccines Revenue Market Share by Type (2018-2034)
Figure 49. Europe Anti-Infective Vaccines Sales Quantity Market Share by Application (2018-2034)
Figure 50. Europe Anti-Infective Vaccines Revenue Market Share by Application (2018-2034)
Figure 51. Europe Anti-Infective Vaccines Revenue Share by Country (2018-2034)
Figure 52. Europe Anti-Infective Vaccines Sales Quantity Share by Country (2018-2034)
Figure 53. Germany Anti-Infective Vaccines Revenue (2018-2034) & (US$ Million)
Figure 54. France Anti-Infective Vaccines Revenue (2018-2034) & (US$ Million)
Figure 55. U.K. Anti-Infective Vaccines Revenue (2018-2034) & (US$ Million)
Figure 56. Italy Anti-Infective Vaccines Revenue (2018-2034) & (US$ Million)
Figure 57. Russia Anti-Infective Vaccines Revenue (2018-2034) & (US$ Million)
Figure 58. China Anti-Infective Vaccines Sales Quantity Market Share by Company in 2022
Figure 59. China Anti-Infective Vaccines Revenue Market Share by Company in 2022
Figure 60. China Anti-Infective Vaccines Sales Quantity Market Share by Type (2018-2034)
Figure 61. China Anti-Infective Vaccines Revenue Market Share by Type (2018-2034)
Figure 62. China Anti-Infective Vaccines Sales Quantity Market Share by Application (2018-2034)
Figure 63. China Anti-Infective Vaccines Revenue Market Share by Application (2018-2034)
Figure 64. APAC Anti-Infective Vaccines Sales Quantity Market Share by Company in 2022
Figure 65. APAC Anti-Infective Vaccines Revenue Market Share by Company in 2022
Figure 66. APAC Anti-Infective Vaccines Sales Quantity Market Share by Type (2018-2034)
Figure 67. APAC Anti-Infective Vaccines Revenue Market Share by Type (2018-2034)
Figure 68. APAC Anti-Infective Vaccines Sales Quantity Market Share by Application (2018-2034)
Figure 69. APAC Anti-Infective Vaccines Revenue Market Share by Application (2018-2034)
Figure 70. APAC Anti-Infective Vaccines Revenue Share by Region (2018-2034)
Figure 71. APAC Anti-Infective Vaccines Sales Quantity Share by Region (2018-2034)
Figure 72. Japan Anti-Infective Vaccines Revenue (2018-2034) & (US$ Million)
Figure 73. South Korea Anti-Infective Vaccines Revenue (2018-2034) & (US$ Million)
Figure 74. China Taiwan Anti-Infective Vaccines Revenue (2018-2034) & (US$ Million)
Figure 75. Southeast Asia Anti-Infective Vaccines Revenue (2018-2034) & (US$ Million)
Figure 76. India Anti-Infective Vaccines Revenue (2018-2034) & (US$ Million)
Figure 77. Middle East, Africa and Latin America Anti-Infective Vaccines Sales Quantity Market Share by Company in 2022
Figure 78. Middle East, Africa and Latin America Anti-Infective Vaccines Revenue Market Share by Company in 2022
Figure 79. Middle East, Africa and Latin America Anti-Infective Vaccines Sales Quantity Market Share by Type (2018-2034)
Figure 80. Middle East, Africa and Latin America Anti-Infective Vaccines Revenue Market Share by Type (2018-2034)
Figure 81. Middle East, Africa and Latin America Anti-Infective Vaccines Sales Quantity Market Share by Application (2018-2034)
Figure 82. Middle East, Africa and Latin America Anti-Infective Vaccines Revenue Market Share by Application (2018-2034)
Figure 83. Middle East, Africa and Latin America Anti-Infective Vaccines Sales Quantity Share by Country (2018-2034)
Figure 84. Middle East, Africa and Latin America Anti-Infective Vaccines Revenue Share by Country (2018-2034)
Figure 85. Brazil Anti-Infective Vaccines Revenue (2018-2034) & (US$ Million)
Figure 86. Mexico Anti-Infective Vaccines Revenue (2018-2034) & (US$ Million)
Figure 87. Turkey Anti-Infective Vaccines Revenue (2018-2034) & (US$ Million)
Figure 88. Israel Anti-Infective Vaccines Revenue (2018-2034) & (US$ Million)
Figure 89. GCC Countries Anti-Infective Vaccines Revenue (2018-2034) & (US$ Million)
Figure 90. Anti-Infective Vaccines Value Chain
Figure 91. Anti-Infective Vaccines Production Process
Figure 92. Channels of Distribution (Direct Vs Distribution)
Figure 93. Distributors Profiles
Figure 94. Bottom-up and Top-down Approaches for This Report
Figure 95. Data Triangulation
Figure 96. Key Executives Interviewed